A Phase Ⅱ Clinical Trial of Recombinant Corona Virus Disease-19 (COVID-19) Vaccine (Sf9 Cells)
Clinical trial NCT04640402 · COMPLETED
Trial details
- NCT number
- NCT04640402
- Sponsor
- Jiangsu Province Centers for Disease Control and Prevention
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-17
- Primary completion
- 2021-02-18
- Enrollment
- 960
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.